Hirepa 0.5 contains Repaglinide (0.5 mg) a fast-acting oral medication specifically designed to help manage blood sugar levels in individuals with type 2 diabetes. By stimulating the pancreas to release insulin after meals Repaglinide effectively controls postprandial blood glucose spikes. This formulation is ideal for patients seeking flexible diabetes management allowing them to tailor their dosage according to meal timing and dietary choices.
Reviews
There are no reviews yet.